Evidence map›Paper›PMID 20516112›Full record

ArticleCancer research2010

Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate.

Jong Wook Kim, Seiichi Mori, Joseph R Nevins

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Telomerase reverse transcriptase regulates microRNAs.International journal of molecular sciences · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Noncoding RNAs in DNA repair and genome integrity.Antioxidants & redox signaling · 2014
    Review
  20. Noncoding RNA in oncogenesis: a new era of identifying key players.International journal of molecular sciences · 2013
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jong Wook KimDuke Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, North Carolina, USA.
Seiichi Mori
Joseph R Nevins
National University of Singapore · SG

Funding

Integration of Oncogenic Networks in Cancer PhenotypesU54CA112952 · NCI · DUKE UNIVERSITY · PI NEVINS, JOSEPH R · 2004 to 2009
$12.4M
Oncogenic Gene Regulatory NetworksR01CA106520 · NCI · DUKE UNIVERSITY · PI CHI, JEN-TSAN ASHLEY · 2005 to 2014
$2.9M
NCI NIH HHS 5 U54 CA112952NCI NIH HHS R01 CA106520NCI NIH HHS U54 CA112952
6 · The paper itself

Abstract

The Myc pathway, often deregulated in cancer, is critical in determining cell fate by coordinating a gene expression program that links the control of cell proliferation with cell fate decisions. As such, precise control of the Myc pathway activity must be achieved to ensure faithful execution of appropriate cellular response and to prevent progressing toward a malignant state. With recent highlighted roles of microRNAs (miRNA) as critical components of gene control, we sought to evaluate the extent to which miRNAs may contribute in the execution of Myc function. Combined analysis of mRNA and miRNA expression profiles reveals an integration whereby the Myc-mediated induction of miRNAs leads to the repression of various mRNAs encoding tumor suppressors that block cell proliferation including p21, p27, and Rb. In addition, the proapoptotic PTEN tumor suppressor gene is also repressed by Myc-induced miRNAs, suggesting that Myc-induced miRNAs contribute to the precise control of a transcriptional program that coordinates the balance of cell proliferation and cell death.

Indexed as

Cell ProliferationBreastCell DifferentiationCells, CulturedFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMicroRNAsProto-Oncogene Proteins c-mycRNA, MessengerTumor Suppressor ProteinsMicroRNAsProto-Oncogene Proteins c-mycRNA, MessengerTumor Suppressor Proteins

Identifiers

PMID20516112
PMCPMC2888768
OpenAlexW2111781151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.